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 2 
Abstract 32 
The JAK/STAT pathway is an essential signalling cascade required for multiple 33 
processes during development and for adult homeostasis. A key question in 34 
understanding this pathway is how it is regulated in different cell contexts. Here we 35 
have examined how endocytic processing contributes to signalling by the single 36 
cytokine receptor, Domeless, in Drosophila melanogaster cells. We identify an 37 
evolutionarily conserved di-Leu motif that is required for Domeless internalisation and 38 
show that endocytosis is required for activation of a subset of Domeless targets. Our 39 
data indicate that endocytosis both qualitatively and quantitatively regulates 40 
Domeless signalling. STAT92E, the single STAT transcription factor in Drosophila, 41 
appears to be the target of endocytic regulation and our studies show that 42 
phosphorylation of STAT92E on Tyr704, while necessary, is not always sufficient for 43 
target transcription. Finally, we identify a conserved residue, Thr702, which is 44 
essential for Tyr704 phosphorylation. Taken together, our findings identify previously 45 
unknown aspects of JAK/STAT pathway regulation likely to play key roles in the 46 
spatial and temporal regulation of signalling in vivo. 47 
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Introduction 49 
The Janus Kinase/Signal transducer and activator of transcription (JAK/STAT) 50 
signalling pathway regulates a variety of cellular events, including proliferation and 51 
apoptosis, throughout development and in adult life (Villarino et al., 2017). According 52 
to the canonical model, JAK/STAT signalling involves the activation of homo- or 53 
hetero-dimerised cell-surface transmembrane receptors by ligands, including 54 
cytokines, growth factors and hormones, which causes a conformational change in 55 
the cytoplasmic tail of the receptor. This stimulates activation of the Janus kinases 56 
(JAKs) that are constitutively associated with the receptor. JAK activation leads to 57 
specific Tyr phosphorylation of both the kinase and the receptor, subsequently 58 
allowing recruitment of signal transducer and activator of transcription (STAT) 59 
transcription factors through Src-homology 2 (SH2) domains. This association in turn 60 
allows JAK to phosphorylate STATs at a highly conserved C-terminal Tyr residue, 61 
leading to STAT dimerization and translocation to the nucleus. Here STATs bind to 62 
palindromic DNA sequences to alter expression of target genes, resulting in 63 
developmental, haematological and immune-related responses (O'Shea et al., 2015; 64 
Stark and Darnell, 2012). Dysregulation of the JAK/STAT pathway is involved in the 65 
pathogenesis of diseases such as gigantism, asthma, myocardial hypertrophy, 66 
myeloproliferative neoplasia and severe combined immunodeficiency (O'Shea et al., 67 
2015). 68 
 69 
The JAK/STAT pathway has been highly conserved through evolution, with 70 
invertebrates such as Drosophila melanogaster having a full complement of pathway 71 
components. However, while mammals have multiple copies of receptors, JAKs and 72 
STATs, in Drosophila the signalling pathway is composed of a single positively acting 73 
receptor, Domeless (Dome) (Brown et al., 2001), a negatively acting receptor, Latran 74 
(Makki et al., 2010), one JAK, Hopscotch (Hop), and one STAT, STAT92E (Hou et al., 75 
1996; Yan et al., 1996; Zeidler and Bausek, 2013). Therefore, Drosophila provides 76 
an excellent model in which to investigate JAK/STAT pathway regulation, without the 77 
difficulties of compensation and signalling crosstalk inherent in mammalian systems. 78 
In fact, investigating JAK/STAT signalling in Drosophila has led to key breakthroughs 79 
in understanding the impact of its dysregulation in human disease (Ekas et al., 2010). 80 
 81 
The repeated use of the JAK/STAT pathway in a variety of contexts begs the 82 
question as to how transcriptional outputs are differentially regulated in a cell- and 83 
tissue-specific manner. One potential mechanism to explain this diversity of outputs 84 
is regulation by endocytosis (Sigismund and Scita, 2018; Villasenor et al., 2016; 85 
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Weinberg and Puthenveedu, 2019). Activated receptors can be internalised into cells 86 
by multiple endocytic pathways of which clathrin mediated endocytosis (CME) is the 87 
best characterised. Receptor complexes internalised by CME are clustered into 88 
clathrin coated pits. The assembled clathrin lattice is linked to the cytoplasmic 89 
domains of transmembrane receptors via adaptor proteins, including the AP2 adaptor 90 
complex (Mettlen et al., 2018; Owen et al., 2004). In addition to CME, several clathrin 91 
independent (CIE) pathways exist which are important for the uptake of particular 92 
cargoes (Mayor et al., 2014). Following internalisation, activated receptors are 93 
delivered to the early endosome where they may be recycled or targeted to late 94 
endosomes and lysosomes for degradation. The Endosomal Sorting Complexes 95 
Required for Transport (ESCRT) protein complexes are key for sorting receptors into 96 
late endosomes and lysosomes. Hrs is a component of ESCRT-0, acting as an 97 
adaptor to select ubiquitinated cargo for targetting to lysosomes. TSG101 is a 98 
component of ESCRT I complexes which recruit other ESCRT complexes, which are 99 
key in allowing the inward invaginations of the late endosome to form intraluminal 100 
vesicles (Henne et al., 2013). Results from in vivo and in vitro experiments indicate 101 
that endocytosis can regulate receptor signalling quantitatively through removal of 102 
activated receptors from the cell surface and targeting them to lysosomes for 103 
degradation. Endocytosis can also qualitatively regulate signalling by establishing 104 
‘signalosomes’, which are membrane microdomains within endosomal compartments 105 
that allow the recruitment of specific scaffolds, adaptors, kinases and phosphatases, 106 
thus resulting in different downstream signalling outputs (Carroll and Dunlop, 2017; 107 
Lawrence et al., 2019; Moore et al., 2018; Sigismund and Scita, 2018; Villasenor et 108 
al., 2016). The route of entry of activated receptors (CME versus CIE) can also 109 
influence signaling output as demonstrated for Notch signaling in Drosophila 110 
(Shimizu et al., 2014) and TGF-beta signaling in mammalian cells (Di Guglielmo et 111 
al., 2003). CME is a major entry portal which has been shown to regulate JAK/STAT 112 
signalling following activation of several different cytokine receptors in mammalian 113 
cells (Cendrowski et al., 2016; Chmiest et al., 2016; German et al., 2011; Kermorgant 114 
and Parker, 2008; Marchetti et al., 2006).  115 
 116 
In vivo studies in Drosophila suggested that Dome-dependent border cell migration 117 
requires ligand-dependent CME and delivery to multivesicular bodies (Devergne et 118 
al., 2007). Mutation of endocytic components including clathrin heavy chain (CHC), 119 
prevented Dome internalisation, decreased STAT92E expression and nuclear 120 
translocation in follicle cells. In contrast, endocytosis appeared to negatively regulate 121 
JAK/STAT signalling in Drosophila Kc167 cells (Müller et al., 2008; Vidal et al., 2010).  122 
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These varying results likely reflect differences due to cell context as has been 123 
observed for endocytic regulation of receptor tyrosine kinases such as epidermal 124 
growth factor receptor (EGFR) (Sousa et al., 2012; Vieira et al., 1996; Villasenor et 125 
al., 2015). The underlying regulatory mechanisms of context-dependent signalling 126 
are however largely unknown.  127 
 128 
Canonical signalling by STAT requires phosphorylation at a conserved Tyr (704 in 129 
Drosophila STAT92E, isoform C used in this study), which allows for parallel 130 
dimerization of STATs via their SH2 domains and translocation into the nucleus. 131 
There is also evidence that other posttranslational modifications, in addition to 132 
phosphorylation of the conserved Tyr, regulate STAT activity (Chung et al., 1997; 133 
Costa-Pereira et al., 2011; Gronholm et al. 2010; Karsten et al., 2006; Wang et al., 134 
2005).  135 
 136 
Here we show that in Drosophila S2R+ cells, endocytosis is essential for the 137 
expression of some, but not all, JAK/STAT pathway target genes. We demonstrate 138 
that STAT92E is the target for endocytic regulation and, importantly, that endocytosis 139 
qualitatively regulates STAT92E activity. In addition, we have identified a novel 140 
phosphorylation site Thr702, which is crucial for Tyr704 phosphorylation of 141 
STAT92E.  142 
  143 
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Results 144 
Dome internalisation requires an evolutionarily conserved di-Leu cassette 145 
To understand mechanisms of Dome internalisation, we first asked how Dome and 146 
its ligand Upd2 are taken into cells. Similar to mammalian cells, Drosophila cells can 147 
internalise material by a variety of CME and CIE mechanisms (Shimizu et al., 2014). 148 
It has been shown that Dome is internalised into Drosophila Kc167 cells by CME 149 
(Müller et al., 2008; Vidal et al., 2010). To investigate if this is the case in S2R+ cells, 150 
we measured internalisation of Upd2-GFP, as a proxy for receptor internalisation, 151 
using an anti-GFP ELISA assay (Wright et al., 2011). We first treated cells with 152 
dsRNA targeting Dome and found that there is a significant reduction in the rate (-153 
38%) and extent (-50%) of uptake of Upd2-GFP at both high (20 nM, Figure 1A) and 154 
low (3 nM, Fig. S1A) concentrations of Upd2-GFP. Under these conditions levels of 155 
Dome mRNA are reduced by ~90% (Figure S1B). The residual uptake of Upd2-GFP 156 
in the absence of Dome is likely due to non-specific fluid phase uptake of ligand. 157 
When cells were incubated with 20nM Upd2-GFP, knockdown of CHC and AP2 158 
reduced the uptake of Upd2-GFP by approximately 60% compared to knockdown of 159 
Dome alone (Figure 1A). Since levels of CHC and AP2 mRNA were reduced by 160 
~80% following dsRNA knockdown, this suggests that the Upd-2-GFP complex can 161 
be internalised by CIE as well as CME, as has been shown for several receptors in 162 
mammalian cells (Sigismund et al., 2005; Vander Ark et al., 2018) and for Notch and 163 
Delta in Drosophila (Shimizu et al., 2014). By contrast, when S2R+ cells were 164 
incubated with low concentrations of Upd2-GFP (3 nM), knockdown of CHC reduced 165 
the uptake of Upd2-GFP to the level observed following Dome knockdown (Figure 166 
S1A). Together this suggests that at low concentrations of Upd2-GFP, Dome is 167 
primarily internalised by CME, but that increasing concentrations of ligand results in 168 
Dome also being internalised via CIE. 169 
 170 
Sorting of cargo into clathrin coated pits requires internalisation motifs in the 171 
cytoplasmic tails of receptors that include both Tyr- and di-Leu-based motifs (Traub, 172 
2003). Dome is most similar in sequence and structure to gp130, which is a co- 173 
receptor shared by receptors for IL-6 (Figure 1B).  Internalisation of gp130 requires a 174 
di-Leu motif (786LL787) in its cytoplasmic domain (Dittrich et al., 1996) while an 175 
upstream serine within the sequence 780SESTQPLL787 has also been shown to be 176 
important for rapid internalisation (Dittrich et al., 1996). Strikingly, the cytoplasmic tail 177 
of Dome also contains a di-Leu motif, 985LL986, in a similar context to that of the di-Leu 178 
motif in gp130 (Figure 1C). In order to test the potential significance of this motif, we 179 
generated a series of FLAG-tagged Dome mutant constructs where individual 180 
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elements of the di-Leu cassette were mutated either alone or in combination (Figure 181 
1C), and transfected these constructs into S2R+ cells. To quantitatively measure 182 
ligand dependent uptake of the engineered Dome constructs, proteins on the surface 183 
of transfected S2R+ cells were biotinylated prior to addition of Upd2-GFP. This 184 
showed that while expression of the mutants was somewhat more efficient than 185 
transfection of wild-type Dome (Figure S1C), plasma membrane expression all of the 186 
constructs was comparable (Figure S1D). Following ligand internalisation, cell 187 
surface biotin was removed by treatment with the reducing agent, 2-188 
mercaptoethanesulfonic acid sodium salt, MESNa, while internalised cell surface 189 
proteins were protected and remained biotinylated. This allowed the amount of 190 
internalised wild-type and mutant Dome to be quantitated. As has been 191 
demonstrated previously for Dome (Ren et al., 2015), we observed ligand-192 
independent internalisation of Dome (Figure S1E). We found that mutation of the 193 
entire di-Leu cassette to AAASKAA (defined from now on as DomeallA) inhibited 194 
internalisation of Dome. Mutation of the di-Leu motif alone (DomeLL985AA-FLAG) did 195 
not significantly reduce internalisation. Using site-directed mutagenesis in which we 196 
progressively replaced elements of the putative cassette, we established that Glu980 197 
and LL985-6 together represent essential residues required for Dome internalisation 198 
(Figure 1D and E). Mutation of Glu980 alone did not significantly affect Dome 199 
internalisation (Figure S1F and S1G). Although uptake of Dome E980G/LL985AA-FLAG 200 
was significantly inhibited (~66%), the effect on internalisation was less than that 201 
observed for the DomeallA-FLAG mutant, suggesting that other determinants may 202 
also be present within the sequence which are important for Dome internalisation 203 
(Figure 1D and 1E). Together these results identify a di-Leu-containing cassette as 204 
being essential for Dome internalisation. 205 
 206 
Dome signalling is regulated by endocytosis 207 
Dome signalling is known to be regulated by endocytosis in Kc167 cells (Müller et al., 208 
2008; Vidal et al., 2010) and in vivo (Devergne et al., 2007). To test whether it is 209 
similarly regulated in S2R+ cells, we measured the expression of the exogenous 210 
reporter 10XSTAT-Luciferase, which expresses the firefly luciferase enzyme under 211 
the control of a minimal promoter downstream of ten STAT92E binding sites (Baeg et 212 
al., 2005). As expected, this reporter is activated in S2R+ cells by exogenous Upd2-213 
GFP, in a dose dependent manner (Figure 2A), indicating that these cells express 214 
the JAK/STAT pathway components required for activation. We next measured 215 
Upd2-GFP-dependent 10xSTAT-Luciferase reporter activity in control cells and those 216 
expressing Dome wt-FLAG or DomeallA-FLAG (Figure 2B).  While expression of 217 
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Domewt-FLAG did not significantly affect signalling, expression of DomeallA-FLAG had 218 
a strong dominant negative effect on Upd2-GFP mediated pathway stimulation. This 219 
effect was comparable to the level observed in cells expressing DomeY966A/Q969A-220 
FLAG and DomeP925I-FLAG, mutants which have been previously reported to have 221 
reduced signalling because of their inability to bind STAT92E (Stahl and 222 
Yancopoulos, 1994) and Hop respectively (Fisher et al., 2016). Levels of expression 223 
of the transfected proteins are shown in Figure S2A. Together these data 224 
demonstrate that Dome mutants that cannot be internalised, also alter JAK/STAT 225 
signalling and are consistent with a model where activation of 10XSTAT-Luciferase 226 
by Upd2-GFP is dependent on Dome internalisation.  227 
 228 
Endocytosis generates qualitatively different transcriptional outputs.  229 
To further explore a role for endocytosis in regulating signalling downstream of 230 
Dome, we asked whether knocking down components of the endocytic machinery 231 
might differentially affect expression of Dome target genes. We therefore examined 232 
the expression of the 10xSTAT-Luciferase reporter and the endogenous target genes 233 
socs36E and lama (Flaherty et al., 2009; Karsten et al., 2002) in cells treated with 234 
dsRNA to knock down endocytic components. We targeted AP2, an adaptor whose 235 
knockdown is predicted to result in accumulation of receptors at the cell surface 236 
(Robinson, 2004), Hrs, an adaptor whose knockdown is likely to result in 237 
accumulation of ubiquitinated receptors in early endosomes, and TSG101 which is 238 
required for the sorting of receptors into intraluminal vesicles and whose knockdown 239 
is likely to lead to an accumulation of receptors on the limiting membrane of late 240 
endosomes (Henne et al., 2013). Treating cells with dsRNA to knockdown Dome 241 
(levels of Dome mRNA were reduced by ~ 90%, Figure S1B) resulted in almost 242 
complete abolition of 10XSTAT-Luciferase expression, demonstrating that both 243 
background, and Upd2-GFP-stimulated, reporter activation are receptor-dependent 244 
(Figure 2C). In the absence of exogenous ligand, activation of 10XSTAT-Luciferase 245 
in cells treated with dsRNA targeting AP2, Hrs or TSG101, was however unchanged 246 
compared to cells treated with control dsRNA (Figure 2C). We speculate that this 247 
ligand-independent activation is due to expression of ligands and growth factors that 248 
may cross-talk with the JAK/STAT pathway in S2R+ cells (Cherbas et al., 2011). By 249 
contrast knockdown of AP2 significantly reduced ligand dependent 10XSTAT-250 
Luciferase activation whereas knockdown of Hrs or TSG101 had no effect. This 251 
indicates that activation of this reporter requires delivery of activated Dome either to, 252 
or beyond, an AP2-positive endocytic compartment but prior to an Hrs-positive 253 
endosomal compartment. We also examined an endogenous target of Dome, 254 
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socs36E (Stec et al., 2013) and found that, in contrast to 10xSTAT-Luciferase 255 
expression, knockdown of both AP2 and Hrs inhibited socs36E mRNA expression 256 
while knockdown of TSG101 had no effect (Figure 2D). This indicates that activated 257 
Dome must be trafficked to an Hrs-positive compartment, or beyond, to allow 258 
downstream pathway activation to trigger socs36E transcription. Taken together 259 
these results indicate that the location of the activated Upd2/Dome complexes within 260 
the endocytic pathway can lead to qualitatively different signalling outputs. It is 261 
important to note that not all Dome target genes are regulated by endocytosis. For 262 
example, expression of lama, a well-characterised target of STAT92E (Flaherty et al., 263 
2009), was unaffected when endocytosis was perturbed, suggesting that expression 264 
of this target gene mRNA can be driven by activated Upd2:Dome complexes which 265 
are located on the plasma membrane (Figure S2B). 266 
 267 
Phosphorylation of STAT92E is necessary, but not sufficient, for transcription of 268 
some JAK/STAT targets 269 
Upon ligand activation of Dome, STAT92E is phosphorylated by Hop at a conserved 270 
Tyr residue (Y704) (Yan et al., 1996). This residue is conserved across all vertebrate 271 
STATs, and its phosphorylation is essential for canonical STAT activity and target 272 
expression. We therefore asked whether Tyr704 phosphorylation of STAT92E was 273 
sensitive to endocytic regulation. One approach to assaying STAT92E 274 
phosphorylation utilizes its change in electrophoretic mobility on SDS-PAGE gels 275 
(Shi et al., 2008), caused by changes in charge and conformation that occur 276 
following phosphorylation (Mao et al., 2005; Wenta et al., 2008). Using this 277 
experimental approach, we observed an Upd2 dose-dependent change in the 278 
electrophoretic mobility of STAT92E following ligand stimulation (Figure 3A and B), 279 
which was reversed by phosphatase treatment (Figure 3C and D). Strikingly, 280 
perturbation of the endocytic pathway, by knockdown of AP2 (Figure 3E and F), or 281 
Hrs or TSG101 (Figure S3), did not affect the temporal dynamics of STAT92E 282 
phosphorylation, a finding that was also confirmed by mass spectrometry (Figure 3G 283 
and Supplemental data 1 and 2, available via ProteomeXchange with identifier 284 
PXD020719). These data demonstrate that phosphorylation of Tyr704 on STAT92E 285 
is not regulated by endocytosis and that other mechanisms must be responsible for 286 
the pathway’s sensitivity to endocytic regulation. 287 
 288 
STAT92E-GFP nuclear import is not affected by knockdown of endocytic 289 
components. 290 
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Canonical JAK/STAT pathway signalling requires nuclear import of the STAT92E 291 
transcription factor to activate gene expression. We therefore investigated whether 292 
knockdown of AP2 impaired translocation of STAT92E into the nucleus. Nuclear 293 
accumulation can be visualized in S2R+ cells transfected with STAT92E-GFP. In the 294 
absence of ligand there appears to be low levels of STAT92E-GFP in the nucleus. 295 
This is consistent with reports that STATs shuttle between the nucleus and 296 
cytoplasm in a phosphorylation-independent manner and that unphosphorylated 297 
nuclear STATs can perform non-canonical functions (Brown and Zeidler, 2008). The 298 
levels of nuclear STAT92E-GFP we observe in the absence of Upd2 is also in 299 
keeping with reports of GFP-tagged proteins entering the nucleus independently of a 300 
nuclear localisation signal (Seibel et al., 2007). When cells are treated with Upd2-301 
GFP (Figure 4A and B), a maximum accumulation is reached after 30 minutes 302 
stimulation. This is comparable to the nuclear accumulation of mammalian STATs 303 
(McBride et al., 2000) and the time-point at which STAT92E phosphorylation is 304 
maximal (data not shown). Consistent with previous studies (Begitt et al., 2000; 305 
Schindler et al., 1992), mutation of STAT92E Tyr704 (Y704F) to prevent 306 
phosphorylation, abolished nuclear accumulation (Figure 4C). While knockdown of 307 
Dome almost completely abolished nuclear accumulation of STAT92E-GFP, 308 
knockdown of either AP2 or Hrs had no significant effect, indicating that endocytic 309 
trafficking of Upd2/Dome does not regulate nuclear accumulation of STAT92E 310 
(Figure 4D). This demonstrates that the loss of target gene expression following AP2 311 
and Hrs knockdown is not likely to be the result of a defect in the translocation of 312 
STAT92E into the nucleus. 313 
 314 
Thr702 phosphorylation is essential for STAT92E activity 315 
Given that Y704 phosphorylation is necessary but not sufficient for STAT92E-driven 316 
pathway gene expression, we wanted to investigate whether other post-translational 317 
modifications of STAT92E might be associated with pathway activation. We 318 
expressed STAT92E-GFP in S2R+ cells, stimulated with Upd2-GFP, and subjected 319 
samples, isolated using GFP-TRAP beads, to mass spectrometry analysis. In 320 
addition to Tyr704, this analysis identified Thr47, Ser227 (Figure 5A, Supplemental 321 
data 1, 3 and 4, available via ProteomeXchange with identifier PXD020719) and 322 
Thr702 (with lower confidence) on STAT92E as being phosphorylated (Supplemental 323 
data 1 and 5, available via ProteomeXchange with identifier PXD020719). We 324 
therefore decided to test the potential physiological relevance of these newly 325 
identified phosphorylation sites using an S2R+ cell line lacking endogenous 326 
STAT92E. We used CRISPr/Cas9 to engineer STAT92E negative S2R+ cells, 327 
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demonstrating that the cell line no longer had detectable STAT92E by Western 328 
blotting (Figure S4A) and T7 endonuclease assay (Figure S4B) and was no longer 329 
able to activate 10xSTAT-Luciferase in response to Upd2-GFP (Figure 5B). As 330 
expected, expression of wild type STAT92E was able to rescue both Upd2-GFP-331 
dependent and -independent 10XSTAT-Luciferase activity (Figure S4C) in these 332 
STAT92E negative cells, while ligand dependent 10XSTAT-Luciferase activity was 333 
further enhanced by expression of STAT92EK187R, a mutant form of STAT92E which 334 
cannot be SUMOylated and which has previously been shown to increase Luciferase 335 
activity (Gronholm et al., 2010). Taken together, these results demonstrate the utility 336 
of the STAT92E negative S2R+ cells for rescue experiments (Figure S4C). 337 
 338 
We next generated mutant forms of STAT92E lacking both known, and candidate, 339 
phosphorylation sites (T47V, S227A, T702V and Y704F), and expressed them in 340 
STAT92E negative S2R+ cells and measured their ability to activate 10xSTAT-341 
Luciferase. Following ligand stimulation with 0.75nM Upd2-GFP, STAT92ET47V 342 
STAT92ES227A and STAT92EWT resulted in comparable levels of 10xSTAT-Luciferase 343 
while STAT92ET702V and STAT92EY704F showed no activation (Figure 5C).  This 344 
indicates that phosphorylation of Thr702 as well as Tyr704, but not Thr47 or Ser227, 345 
is required for JAK/STAT signalling.  346 
 347 
Phosphomimetic forms of STAT92E rescue signalling 348 
To further explore the role of Thr702 phosphorylation in STAT92E mediated gene 349 
activation, we generated phosphomimetics of Thr702 (STAT92ET702D, STAT92ET702E) 350 
and tested their effects on the 10xSTAT-Luciferase reporter. Using the STAT92E 351 
negative S2R+ cell assays, we first showed that expression of ‘loss-of-352 
phosphorylation’ mutants STAT92ET702V and STAT92EY704F did not stimulate reporter 353 
activity above background levels (Figure 5D). By contrast, expression of both 354 
phosphomimetics STAT92ET702D and STAT92ET702E were sufficient to increase both 355 
ligand-dependent and ligand-independent 10xSTAT-Luciferase expression, with 356 
STAT92ET702D more effective in both cases. Taken together, we have thus identified a 357 
novel posttranslational modification of STAT92E which is essential to trigger 358 
transcriptional activity in this assay. 359 
 360 
Phosphorylation of Thr702 is required for Tyr704 phosphorylation  361 
We next asked whether Thr702 phosphorylation is required for nuclear translocation 362 
of STAT92E and found that Upd2-GFP does not stimulate STAT92ET702V 363 
translocation into the nucleus (Figure 6A and B). Using mass spectrometry, we found 364 
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that STAT92ET702V showed a substantial reduction in Tyr704 phosphorylation (Figure 365 
6C, Supplemental Data 1 and 6, available via ProteomeXchange with identifier 366 
PXD020719). This indicates that phosphorylation of Thr702 is essential for efficient 367 
phosphorylation of Tyr704 which, in turn, is essential for the bulk of canonical 368 
JAK/STAT gene expression.   369 
  370 
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Discussion 371 
In this work we have explored regulatory mechanisms of JAK/STAT signalling 372 
following Upd2-dependent Dome activation in Drosophila S2R+ cells. We have 373 
identified an evolutionarily conserved internalisation motif in the cytoplasmic tail of 374 
Dome. We have demonstrated that internalisation and endocytic trafficking of 375 
activated Dome allows for compartmentalised signalling to regulate subsets of 376 
Drosophila JAK/STAT transcriptional targets, through a mechanism that is 377 
independent of Tyr704 phosphorylation of STAT92E. We have also demonstrated 378 
that phosphorylation of Thr702 is essential for Tyr704 phosphorylation of STAT92E, 379 
its translocation to the nucleus and its activity as a transcription factor.  380 
 381 
It has been shown that Dome enters cells by CME in vivo in Drosophila (Devergne et 382 
al., 2007) and in vitro in Kc167 cells (Müller et al., 2008; Vidal et al., 2010). Our results 383 
also support a role for CME in Dome uptake in S2R+ cells since dsRNA mediated 384 
knockdown of CHC and AP2 reduce Upd2-GFP internalisation. There are a number 385 
of defined motifs that allow the inclusion of transmembrane receptors into clathrin 386 
coated pits, through interactions with adaptor molecules such as AP2. A di-Leu motif 387 
is one such motif, which is well documented to bind to the α-σ2 hemicomplex of AP2 388 
(Doray et al., 2007; Kelly et al., 2008). In this work we have demonstrated that such a 389 
motif is part of a cassette, which is essential for efficient internalisation of Dome. 390 
Interestingly, a di-Leu-containing cassette is also required for the internalisation of 391 
gp130, the closest vertebrate homologue of Dome and the co-receptor for IL-6R, 392 
which is necessary for IL-6R internalisation (Dittrich et al., 1996). Similar to gp130, 393 
mutation of the di-Leu motif alone in Dome was insufficient to completely abolish 394 
internalisation. In the case of gp130, a Ser upstream of the di-Leu motif was also 395 
shown to be involved in rapid internalisation. We found that mutation of the 396 
equivalent Ser, in combination with mutation of the di-Leu motif, further reduced 397 
Dome internalisation although still not to the same extent as in the DomeallA mutant. 398 
An acidic residue (Glu or Asp) at -4 position is commonly found adjacent to di-Leu 399 
motifs, and its mutation has previously been shown to drastically decrease binding to 400 
the α- σ2 hemicomplex of AP2 (Doray et al., 2007). Mutation of this charged residue 401 
alone had no effect on receptor internalisation, while mutation of both the Glu and di-402 
Leu reduced internalisation by approximately 66% compared to Domewt. This 403 
suggests that while the Glu and di-Leu are important, other residues may also 404 
influence Dome internalisation. It also points to an important evolutionary 405 
conservation in mechanisms of Dome internalisation in line with the conservation of 406 
JAK/STAT pathway components across species.  407 
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 408 
Our results support a role for CIE, in addition to CME, in uptake of activated Dome in 409 
S2R+ cells. While dsRNA-mediated knockdown of CHC and AP2 inhibits 410 
internalisation of Upd2-GFP/Dome, the extent of inhibition depends on the 411 
concentration of the Upd2-GFP ligand. At low concentrations (3 nM) of Upd2-GFP, 412 
there is an absolute requirement for CHC and AP2, whereas at higher concentrations 413 
(20 nM), uptake of Upd2-GFP/Dome in cells treated with dsRNA targeting CHC and 414 
AP2 is inhibited by approximately 50% compared to cells treated with dsRNA 415 
targeting Dome. This is consistent with studies in Drosophila where uptake of Notch 416 
and Delta through different endocytic pathways (CME and CIE) leads to delivery to 417 
different endosomal compartments and differential signalling and the balance of flux 418 
between these pathways allows cells to respond to different environmental conditions 419 
(Shimizu et al., 2014). Similarly, in mammalian cells, activated receptor tyrosine 420 
kinases such as TGF-beta receptors and EGFR can be taken up by CME and CIE, 421 
with CME being favoured at lower ligand concentrations (Di Guglielmo et al., 2003; 422 
Sigismund et al., 2005). As with Notch signalling, the route of entry of the receptors 423 
can determine signalling outcome and receptor fate (Sigismund et al., 2013; Vander 424 
Ark et al., 2018). The concept of endocytosis modulating Dome target gene 425 
expression in different cells and tissues is supported by previous in vitro and in vivo 426 
studies (Devergne et al., 2007l; Silver et al., 2005; Vidal et al., 2010). Our 427 
experiments, which have focussed on CME of activated Dome, indicate that 428 
endocytosis also regulates a subset of Dome signalling in S2R+ cells. Mutation of the 429 
internalisation motif not only prevents Dome uptake but also prevents Dome 430 
activation of 10XSTAT-Luciferase, consistent with a role for endocytosis in activation 431 
of target genes.  It is noteworthy that we observe constitutive internalisation and 432 
recycling of Dome in the absence of ligand, as has been observed, in mammalian 433 
cells, for other cytokine receptors (Thiel et al., 1998). Regulation of constitutive 434 
recycling provides cells with a mechanism to control cell surface levels of receptor, 435 
which in turn will impact on the magnitude of signalling (Moore et al., 2018). 436 
 437 
Strikingly, we have demonstrated that endocytosis of Dome allows an additional level 438 
of regulatory control in that delivery to distinct endosomal populations can further 439 
affect signalling outcome. Endocytosis is not required for expression of all genes, e.g. 440 
lama, which is still expressed even when components of the endocytic machinery are 441 
ablated with dsRNA. By contrast, expression of 10XSTAT-Luciferase requires 442 
delivery to, or beyond, an AP2-positive compartment, and expression of socs36E 443 
only occurs when activated Dome has trafficked through an Hrs-positive 444 
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compartment, but before it has reached a TSG101-positive compartment (Figure 6D). 445 
Our data thus demonstrate that qualitatively different signalling outputs can occur 446 
depending on the location of the activated receptor within the endocytic pathway. 447 
This strongly supports the concept that the rate at which receptors, in this case 448 
Dome, move through the pathway (endocytic flux) is key for signalling outputs and 449 
will have profound effects on downstream cell behaviours. This is consistent with 450 
studies on EGFR signalling which imply that receptor signalling can modulate the 451 
endocytic machinery to determine the rate of receptor flux (Villasenor et al., 2015). 452 
Although mechanistic details for endocytic regulation of signalling are better 453 
understood for RTKs and GPCRs, there is a considerable body of emerging 454 
evidence to support a role for endocytic regulation of cytokine receptors in 455 
mammalian cells (Cendrowski et al., 2016). Our data are thus consistent with a 456 
variety of studies in mammalian cells demonstrating an instructive role for 457 
endocytosis in JAK/STAT signalling (Cendrowski et al., 2016; Chmiest et al., 2016; 458 
German et al., 2011; Kermorgant and Parker, 2008; Marchetti et al., 2006). 459 
 460 
In Drosophila, STAT92E is the single transcription factor utilised by the JAK/STAT 461 
pathway to control expression of many different target genes, which are expressed in 462 
a tissue-specific and developmentally-regulated manner. The essential role of Tyr704 463 
phosphorylation in JAK/STAT signalling is well-established (Yan et al., 1996). We 464 
eliminated the possibility that endocytosis is required for STAT92E phosphorylation 465 
by demonstrating that STAT92E is phosphorylated to the same extent, even when 466 
components of the endocytic machinery, such as AP2, are knocked down by dsRNA. 467 
More importantly what our data demonstrate is that STAT92E Tyr704 468 
phosphorylation, although necessary, is not sufficient for the expression of all Dome 469 
target genes.  Our data are consistent with previous studies showing that a mutant 470 
form of STAT92E, which cannot be methylated is hyper phosphorylated but has a 471 
dominant negative effect on target gene expression (Karsten et al., 2006).  472 
 473 
When the endocytic pathway is disrupted, phosphorylated STAT92E can still 474 
translocate into the nucleus but it is no longer fully signalling competent. This implies 475 
that Dome needs to reach a particular endosomal subcompartment or microdomain 476 
in order to allow STAT92E to become transcriptionally competent. Of particular 477 
interest is the post-Hrs and pre-TSG101 compartment required for socs36E 478 
expression (Figure 6D). Hrs is a component of ESCRT-0 complex that recognises 479 
ubiquitinated signalling cargo destined to be packaged into inward invaginations of 480 
the endosomal membrane to form ILVs and ultimately multivesicular bodies. TSG101 481 
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is required for later stages of ILV formation (Vietri et al., 2019). As such both these 482 
components are found within the same limiting membrane. It has been proposed that 483 
membrane microdomains of defined composition, containing signalling molecules, 484 
must be able to form within endosomal membranes to generate local signalling 485 
competent (signalosome) domains (Shimizu et al., 2014; Teis et al., 2002). Within 486 
these specialised signalosomes, STAT92E is likely either to undergo additional 487 
posttranslational modifications or to acquire a chaperone protein that facilitates its 488 
ability as a transcription factor for a subset of target genes. Support for a Hrs 489 
signalosome comes from studies that demonstrate that the Hrs interacting protein 490 
STAM is required for downstream signalling following IL2-R activation (Takeshita et 491 
al., 1997; Tognon et al., 2014). In mammals, STAMs are phosphorylated in response 492 
to a range of cytokines and growth factors (Pandey et al., 2000). The Hrs/STAM 493 
complex remains an interesting link between signalling and endocytosis, as it has 494 
been shown to have both positive and negative roles in the regulation of RTK 495 
signalling in Drosophila, which are dependent on the specific tissue and 496 
developmental stage (Chanut-Delalande et al., 2010). 497 
 498 
Previous studies in mammalian cells have shown that endosomal location is required 499 
for STAT3 activation by activated c-Met which is classed as a weak activator, and it 500 
was proposed that by localising STAT3 activation in endosomes, nuclear import is 501 
facilitated (Kermorgant and Parker, 2008). Here we show the importance of 502 
localisation at different points along the endocytic pathway to nuance Dome 503 
signalling to allow different signalling outputs with STAT92E being a target for 504 
endocytic regulation. 505 
 506 
Mass spectrometry analysis revealed Thr702 as a novel phosphorylation site on 507 
STAT92E that is functionally important. Mutation to Val which is structurally similar 508 
but cannot be phosphorylated, prevented STAT92E Tyr704 phosphorylation and 509 
nuclear translocation, while phosphomimetic forms of Thr702 rescued this phenotype. 510 
Alignment (Waterhouse et al., 2018) of STAT92E with the published crystal structure 511 
of STAT1 (Chen et al., 1998) suggests that Thr702 and Tyr704 are located in a 512 
flexible loop region (Figure 6E). Phosphorylation is likely to have significant effects 513 
on the conformation of this region. Intriguingly this Thr is conserved in STAT1 and is 514 
a phosphomimetic in STAT5 suggesting that it may play a role in ensuring effective 515 




In summary we have shown that endocytosis regulates JAK/STAT signalling in 519 
Drosophila S2R+ cells resulting in qualitatively different signalling outputs. We 520 
therefore suggest that the endocytic flux of activated Dome provides a mechanism by 521 
which JAK/STAT can regulate different cellular behaviours depending on cell context. 522 
In the course of our studies we have shown that while phosphorylation of Tyr704 on 523 
STAT92E is necessary, it is not sufficient for expression of some JAK/STAT target 524 
genes. Moreover for some targets, delivery to an endosomal sub-compartment is 525 
required in order to make STAT92E transcriptionally competent. 526 
 527 
  528 
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Methods 529 
Cell culture  530 
S2R+ cells were cultured at 25°C in Schneider’s Insect Tissue Culture media (Gibco, 531 
UK), supplemented with 10% heat inactivated FBS (Sigma, UK.), penicillin (1,000 532 
units/ml) and streptomycin (0.1 mg/ml) (Sigma, UK) and 2 mM L-Glutamate (Gibco, 533 
UK). Cells were grown to confluency in T75cm2 flasks and routinely passaged at a 1:3 534 
dilution every 3-4 days.  535 
 536 
Cell Transfection  537 
For expression of STAT92E-GFP or Dome-FLAG, cells were seeded a day prior to 538 
transfection. They were transfected at a ratio of 2 µg DNA/1x106 cells in a 6 well plate, 539 
using Effectene Reagent (Qiagen Ltd, UK) and used 2 days later for experiments. 540 
 541 
Upd2-GFP production 542 
Upd2-GFP conditioned media was produced essentially as described (Wright et al., 543 
2011) with the following modifications: S2R+ cells were seeded at 1x106 cells per well 544 
of a 6-well plate 1 day prior to transfection. pAct-Upd2-GFP (2µg per well) was 545 
transfected using Effectene Transfection Reagent (Qiagen Ltd, UK) following the 546 
manufacturer’s instructions. After 2 days, 3 wells of transfected cells were transferred 547 
to a T75 cm2 flask and incubated for a further 4 days. Cells were centrifuged at 1000 548 
x g for 3mins, and media was filtered, aliquoted and snap-frozen in liquid N2 and 549 
stored at -80°C.  The concentration of Upd2-GFP was determined using an ELISA for 550 
GFP (see below). Mock conditioned media (referred to as mock treatment) was 551 
produced by transfecting cells with 2 µg pAc5.1 and processed as above. 552 
 553 
dsRNA knockdown 554 
dsRNAs were obtained from the Sheffield RNAi Screening Facility whose dsRNA 555 
database is based on the Heidelberg 2 library (Boutros lab), generated with Next-556 
RNAi (Horn et al., 2010). It is the redesigned, non-off target effect library, HD2.0 557 
generated using the software next-RNAi (developed by Thomas Horn). Low 558 
complexity regions and sequence motifs that induce off-target effects have been 559 
excluded. dsRNA probe sizes vary from 81 to 800bp covering ~14000 protein 560 
encoding genes and ~1000 non-coding genes (~98.8% coverage). The dsRNA 561 
design covers every isoform of each gene and has been optimised for specificity and 562 
avoidance of low complexity regions. The following dsRNA amplicons were used; 563 
Alpha-adaptin (BKN20148); CHC (BKN20463); Dome (BKN25660); Hrs (BKN27923); 564 
TSG101 (BKN28961). Negative control dsRNA was a mixture of 3 amplicons 565 
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targeting C. elegans mRNA (BKN70003, BKN70004, BKN70005). Amplification of 566 
dsRNA was carried out using MEGAscript® RNAi Kit (Life Technologies #AM1626), 567 
and purified via ethanol precipitation with sodium acetate, followed by resuspension 568 
in sterile water. 569 
Cells were seeded one day prior to knockdown, and resuspended in serum free 570 
media on the day of knockdown. The desired number of cells was added to the wells 571 
already containing dsRNA and incubated for 1hr at 25°C (15 µg of dsRNA plus 1x106 572 
cells per well in a 6-well plate). After incubation, an equal volume of fresh media 573 
containing 20% FBS was added. Cells were incubated at 25°C for a total of 5 days 574 
before subsequent experiments. Transfection with STAT92E-GFP was performed on 575 
day 3 of dsRNA treatment. 576 
 577 
Generation of CRISPr S2R+ cell lines 578 
sgRNA were designed to target the N-terminal coding region of STAT92E and 579 
showed <1% chance of off-target activity (crispr.mit.edu). Sequences were also 580 
verified using NCBI blast to eliminate potential off-targets. The NGG sequence was 581 
then removed, and a G was added to the 5’ end of the sgRNA sequence to allow 582 
transcription from the U6 promoter in pAc-sgRNA-Cas9 vector. sgRNA oligos (Table 583 
1) were cloned into the pAc-sgRNA-Cas9 expression vector according to the 584 
published protocol (Bassett et al., 2014). S2R+ cells were plated at 5x105cells per well 585 
in a 12-well plate and transfected with 1 µg pAc-sgRNA-Cas9 construct using 586 
Effectene (Qiagen Ltd, UK). After 3 days, puromycin (5 µg ml-1) selection was 587 
performed for 7 days before subsequent analysis (Bassett et al., 2014).  588 







To detect Cas9 induced mutations within the genomic DNA of S2R+ CRISPR cell 589 
lines, a T7 endonuclease assay was carried out to identify mismatched, heteroduplex, 590 
DNA. PCR products were first produced by amplifying a ~1 kb region around the 591 
Cas9 cut site with a 50 µl PCR reaction according to the following method (Guschin 592 
et al., 2010). Following verification of size on agarose gels, PCR products were 593 
denatured and annealed to form heteroduplexes in the following reaction: 5-10 µl 594 
PCR products, 2 µl NEBuffer 2 made up to 19 µl with nuclease free water. The 595 
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reaction was heated at in a 95˚C heat block for 10mins and allowed to cool to room 596 
temperature. 1 µl of T7 endonuclease was then added to reactions and incubated at 597 
37˚C for 15 mins. The reaction was stopped by addition of 1.5 µl 0.25 M EDTA 598 
before running on an agarose gel. 599 
 600 
ELISA assay for GFP 601 
The anti-GFP ELISA was performed essentially as described (Wright et al., 2011). 602 
Briefly, 96-well high-binding EIA plate (Costar) was coated with 0.0625 µg ml-1 goat 603 
anti-GFP antibody (Abnova #PAB10341) in 100mM Sodium Bicarbonate overnight at 604 
4°C. The plate was washed 3x with wash buffer (0.2% (w/v) BSA, 0.5% Triton-X 100 605 
in PBS) and then blocked in the same buffer for 1 h at RT. A serial dilution of 606 
recombinant GFP (Cellbiolabs, STA-201), starting at 5 ng ml-1, was plated for 607 
reference. Samples were incubated for 3 h at 37°C. After washing, the plate was 608 
incubated with rabbit anti-GFP (Abcam, Ab290) at 1:20,000 for 2h at RT. After further 609 
washes, the plate was incubated with a secondary HRP-linked anti-rabbit antibody 610 
(Santa Cruz, sc-2004) at 1:5000 for 1h at RT. Following washing, 200 µl per well of 611 
freshly prepared HRP developing solution (0.012% H2O2, 0.4 mg ml-1 o-612 
phenylenediamine in HRP assay buffer: 51 mM Na2HPO4, 27 mM citric acid, pH 5.0, 613 
(filtered)) was added to the plate and colour change was observed. To stop the 614 
reaction 50 µl of 2 M H2SO4 was added per well and the absorbance read at 492 nm 615 
on a BMG Labtech plate reader.  616 
 617 
Endocytosis assays using anti-GFP ELISA 618 
Cells were seeded in a 24 well plate (2x105 cells per well) a day prior to experiment. 619 
Media was replaced with conditioned media containing established concentrations of 620 
Upd2-GFP and incubated at 25°C for various times. Endocytosis was stopped by 621 
placing cells on ice and washing twice with ice-cold PBS. Cell-surface ligand was 622 
removed by 2x acid washing with 0.2M glycine, 0.15M NaCl pH 2.5 for 2mins. Cells 623 
were then washed again in PBS before lysis in ELISA lysis buffer (PBS containing 1 624 
mM MgCL2, 0.1% (w/v) BSA, 0.5% Triton-X 100 supplemented with cOmplete™, Mini, 625 
EDTA-free Protease Inhibitor Cocktail (Roche #11836170001)). 626 
 627 
Endocytosis assays using cell surface biotinylation 628 
All reactions were carried out on ice unless specified. Growth media was aspirated 629 
from cells which were washed 2x with ice-cold PBS. Cells were incubated for 1 hr on 630 
ice with freshly prepared EZ-linkTM Sulfo-NHS-SS-Biotin (Thermo Scientific™) (0.25 631 
mg ml-1) before biotin was quenched by washing twice with PBS containing 100 mM 632 
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glycine. Internalisation was allowed to proceed for various times by adding pre-633 
warmed Upd2-GFP and incubating at 25°C. Cells were returned to ice and washed 634 
2x with PBS. Cell surface biotin was cleaved by washing cells 3x for 20 mins with 635 
MESNa (100 mM 2-mercaptoethanesulfonate, added fresh for each incubation to 636 
50mM Tris-HCL pH8.6, 100 mM NaCl, 1 mM EDTA, 0.2% (w/v) BSA). Cells were 637 
then washed 3x in PBS. Reduced disulphide bonds were alkylated for 10mins with 638 
500 mM Iodoacetamide in PBS, before a final 2x PBS wash. Cells were then lysed 639 
for 30 mins and lysates were centrifuged at 13,000 rpm for 10 mins. Streptavidin-640 
agarose (15µl) was washed 3x with lysis buffer and incubated with cell lysate (10-641 
30µg) overnight at 4°C with rotation. Beads were then washed 3x with lysis buffer 642 
and boiled for 5mins at 95°C in 20 µl Laemmli SDS-PAGE buffer before SDS-PAGE 643 
and Western blotting.  644 
 645 
Lysis buffer: 20 mM Tris pH7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton 646 
X-100, 1 mM β-Glycerophosphate, 25 mM Na-Pyrophosphate, 1 mM Na3VO4, 647 
1 µg ml-1 microcystin, 25mM N-ethylmaleimide supplemented with cOmplete™, 648 
Mini, EDTA-free Protease Inhibitor Cocktail (Roche #11836170001). 649 
 650 
10xSTAT-Luciferase detection 651 
Cells were seeded in a 12-well plate at 5x105 cells per well a day prior to transfection. 652 
Cells were transfected with 0.5 µg 10xSTAT-luciferase and 0.5 µg pAct-Renilla 653 
(internal control for transfection) for 1 day and then transferred to a 96-well plate at 654 
5x104 cells per well. Cells were treated with conditioned media containing Upd2-GFP 655 
for 18hrs. Luciferase activity was measured using the Dual-Glo Luciferase Assay 656 
System (Promega), following manufacturer’s instructions, using a 1:5 dilution of 657 
DualGlo-luciferase in distilled water. The Dual-Glo Stop and Go Luciferase Assay 658 
reagent (1:5 dilution) was added to the plate at an equal volume to the culture media 659 
in the wells, and incubated for at least 10mins. The Luciferase firefly signal was 660 
measured using a Thermo ScientificTM Varioskan Flash Luminometer. An equal 661 
volume of Dual-Glo Stop & Glo Reagent was then added and incubated for at least a 662 
further 10 mins to allow measurement of the Renilla firefly (RL) signal. Luciferase 663 
activity is calculated as Firefly luciferase value normalized to the internal transfection 664 
control (RL). 665 
 666 
Calf intestinal alkaline phosphatase (CIP) treatment 667 
STAT92E was immunoprecipitated from cells lysed in lysis buffer (PBS containing 1 668 
mM MgCl2, 0.1% (w/v) BSA, 0.5% Triton-X 100 supplemented with cOmplete™, Mini, 669 
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EDTA-free Protease Inhibitor Cocktail (Roche)). CIP (#M0290S NEB) 1 unit per 1µg 670 
protein was incubated for 1 hr at 37°C. Reaction was stopped by addition of sample 671 
buffer and boiling at 95°C for 5 mins. 672 
 673 
Quantitative PCR  674 
RNA extraction was carried out using TRI reagent (Sigma #T9424) and reverse 675 
transcribed using the High Capacity RNA-tocDNA™ Kit (Applied Biosystems 676 
#4387406). cDNA was diluted 1:10 and relative mRNA levels of socs36E, Dome, 677 
lama, AP2, Hrs and TSG101 were quantified using qPCR. This was performed using 678 
SYBR Green JumpStart™ Taq ReadyMix™ (Sigma #S4438) and primers, listed in 679 
Table 2, on the BioRad CFX96 Real time system, C100 TouchTM thermal cycler or the 680 
Applied Biosystem QuantStudio 12K Flex. A standard curve of diluted template was 681 
used to interpolate the quantity of target gene in the test samples. Results for each 682 
target were normalised to levels of the reference gene, ribosomal protein L32 (Rpl32) 683 
mRNA, within each well. 684 
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Site-directed mutagenesis 686 
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Site-directed mutagenesis was carried out using the QuikChange Site-Directed 687 
Mutagenesis Kit (Agilent Technologies) according to manufacturer’s instructions.  688 
Sequencing of plasmid DNA was carried out at the University of Sheffield’s Core 689 
Genomic Facility and results analysed using ApE. 690 
 691 
Mass spectrometry methods 692 
A detailed description of mass spectrometry methods (sample preparation, mass 693 
spectrometry analysis and data processing) together with mass spectrometry data 694 
and annotated relevant spectra (phosphorylated Y704, T47, S227, and T702) has 695 
been deposited to the ProteomeXchange Consortium via the PRIDE partner 696 
repository (Deutsch et al., 2020). The identifier number of the dataset is PXD020719. 697 
 698 
Immunofluorescence detection of nuclear and cytoplasmic STAT92E-GFP 699 
A DeltaVision/GE Healthcare OMX optical microscope (version 4) with oil-immersion 700 
objective (60x NA 1.42, PlanApochromat Olympus) was used for widefield and SIM 701 
immunofluorescence image acquisition. Deconvolution and image registration (for 702 
alignment of SIM images) was carried out using the DeltaVision OMX softWoRx 6.0 703 
software. Analysis of microscopy images was carried out using ImageJ. Four regions 704 
of interest (ROI) of equal size were drawn within each transfected cell: two within the 705 
nucleus and two within the cytoplasm. Intensity measures were averaged for the 706 
nucleus and divided by the average intensity for the cytoplasm. 707 
 708 
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Abbreviations: 720 
JAK/STAT: Janus Kinase/Signal transducer and activator of transcription 721 
CME: clathrin-mediated endocytosis 722 
CIE: clathrin independent endocytosis 723 
ESCRT: Endosomal sorting complexes required for transport 724 
Dome: Domeless 725 
EGFR: epidermal growth factor receptor 726 
RL: Renilla Luciferase  727 
FL : 10xSTAT-Luciferase  728 
CIP: Calf intestinal phosphatase 729 
 730 
 731 
  732 
 26 
Figure Legends 733 
Figure 1: Uptake of Upd2-GFP into S2R+ cells is Dome-, clathrin-, and AP2 734 
dependent  735 
(A) S2R+ cells were treated for 5 days with control, clathrin (CHC), AP2, or Dome 736 
dsRNA. Cells were incubated with 20 nM Upd2-GFP for indicated time points at 737 
25°C. Following acid washes, cell lysates were analysed with an anti-GFP ELISA. 738 
Internalised Upd2-GFP is expressed as percentage of the total amount internalised 739 
at 30 minutes. Data represent mean +/- s.d. of two independent experiments. Data 740 
were fitted using the non-linear least squares fit in Prism. 741 
(B) Schematic of Drosophila Dome and the vertebrate gp130/IL6-R complex.  742 
(C) A di-Leu cassette in the cytoplasmic tail of gp130 and Dome, and mutants 743 
generated to investigate internalisation motifs. Note DomeAAASKAAL is referred to as 744 
DomeallA in the text. 745 
(D) Quantitation of internalisation of Dome-FLAG wild-type and mutants: Percentage 746 
of cell-surface receptor that is internalised after 15 mins at 25°C. Background of 747 
biotinylated cell surface Dome-FLAG after 0 mins endocytosis and MESNa treatment 748 
was subtracted and internalised Dome-FLAG was then calculated as a percentage of 749 
total cell surface Dome-FLAG prior to MESNa treatment. Graphs represent mean +/- 750 
s.e.m. for at least 3 independent experiments (DomeE980A/LL985AA = 3 repeats, all other 751 
mutants ≥ 4 repeats). *: p<0.5; **: p<0.01; ***: p< 0.001 752 
(E) Sample immunoblot of lysates from cells transfected with DomeWT-FLAG, 753 
DomeallA-FLAG, DomeLL985AA-FLAG, DomeE980G/LL985AA-FLAG, DomeS979A/LL985AA-FLAG, 754 
or DomeS981A/LL985AA-FLAG, for 48 hrs prior to cell surface biotinylation and incubation 755 
at 25°C for times indicated +/- Upd2-GFP and +/-MESNa. Western blots were probed 756 
with antibodies as indicated.  757 
 758 
Figure 2:  Endocytosis regulates Dome target gene expression. 759 
(A) Expression of 10xSTAT-Luciferase reporter is Upd2-GFP dependent. S2R+ 760 
cells were transfected with an actin driven Renilla Luciferase (RL) and 10xSTAT-761 
Luciferase (FL) reporter construct for 6hrs and then treated with varying 762 
concentrations of Upd2-GFP for 30mins, followed by incubation for 18hrs in fresh 763 
media, before bioluminescence was measured. Graph represents mean +/- s.d. of 2 764 
experiments, each performed in triplicate. 765 
(B) Mutation of Dome internalisation motifs inhibits Upd2-GFP-induced 10xSTAT-766 
Luciferase reporter activation. S2R+ cells were transfected with pAc- Ren (RL), 767 
10xSTAT-luciferase (FL) reporter and pAc5.1 (-) and DomeWT-FLAG, DomeallA-FLAG, 768 
DomeY966A/Q969A-FLAG or Dome P925I-FLAG. Cells were stimulated with 0.75 nM Upd2-769 
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GFP for 30 mins, then incubated in fresh media for 18 hrs. Luciferase activity (FL/RL) 770 
is presented as a fold change compared to mock treated cells transfected with pAc5.1 (-). 771 
Graph represents mean of triplicates +/- s.e.m. for 4 independent experiments. 772 
Parametric, unpaired student’s t-test was performed, **: p≤0.01, ***: p≤0.001, ns: not 773 
significant.  774 
(C) S2R+ cells were transfected with RL and FL for 6hrs prior to treatment with 775 
dsRNA targeting Dome, AP2, Hrs or TSG101 or control (non-targeting), and 776 
incubated for five days. Cells were treated with Upd2-GFP for 18hrs and then 777 
bioluminescence was measured. Luciferase activity (FL/RL) is normalised to control, 778 
mock treated, cells. Graph represents mean of triplicates +/- s.e.m. for 4 experiments. 779 
Parametric, unpaired student’s t-test carried out to compare Upd2-GFP stimulated 780 
samples only, with *: p≤0.05, ****: p≤0.0001. 781 
(D) S2R+ cells were treated with dsRNA against AP2, Hrs and TSG101 as well as 782 
non-targeting (control) dsRNA for 5 days. Cells were incubated with 3 nM Upd2-GFP 783 
for 2.5 hrs prior to RNA extraction. socs36 mRNA levels were normalised to that of 784 
reference gene Rpl32, and presented as fold change compared to mock-treated 785 
control samples. Results are expressed as means of triplicates +/- s.e.m. for 3 786 
independent experiments. Parametric, unpaired student’s t-test was carried out to 787 
compare Upd2-GFP stimulated samples only. **: p≤0.01  788 
 789 
Figure 3: Tyr704 phosphorylation of STAT92E is independent of endocytic 790 
regulation 791 
(A) Western blot showing that Upd2-GFP causes a concentration dependent 792 
bandshift, indicative of phosphorylation, of STAT92E. The positions of the non-793 
phosphorylated and phosphorylated forms are indicated on the blot.  794 
(B) Graph represents quantitation of phosphorylated STAT92E as a function of 795 
Upd2-GFP concentration. Phosphorylated STAT92E is expressed a % of total 796 
STAT92E. 797 
(C) S2R+ cells were treated with 3 nM Upd2-GFP for 10mins and lysates incubated 798 
with anti-STAT92E antibodies. Immunoprecipitated protein was then treated with calf 799 
intestinal phosphatase (CIP), and analysed by SDS-PAGE and immunoblotting with 800 
anti-STAT92E antibodies. p-STAT92E and STAT92E are indicated by arrows. 801 
(D) Quantitation of p-STAT92E/STAT92E ratio +/- phosphatase treatment 802 
(E) Representative immunoblot of control vs AP2 knockdown S2R+ cells treated with 803 
3 nM Upd2-GFP at 25°C for the indicated times. Cells were treated with targeting 804 
dsRNA cells and incubated for 5 days at 25°C. Total protein extract was analysed by 805 
SDS-PAGE and immunoblotted with anti-STAT92E antibodies. 806 
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(F) Quantification of STAT92E phosphorylation after AP2 knockdown. 807 
Phosphorylated STAT92E is expressed as % total STAT92E. Results are expressed 808 
as mean +/- s.e.m. from 4 independent experiments. Using student’s t-test there are 809 
no statistically significant differences between control and AP2 knockdown samples. 810 
(G) Upd2-dependent phosphorylation of Tyr704 is unchanged following dsRNA 811 
mediated knockdown of AP2. S2R+ cells treated with control and AP2 dsRNA were 812 
transfected with STAT92E-GFP and treated with 3 nM Upd2-GFP for 75 min. Cells 813 
were lysed and incubated with GFP-trap beads prior to preparation for mass 814 
spectrometry analysis. Histograms present the ratios Mod/Base of the Y704 815 
phosphorylation site from STAT92E-GFP calculated by MaxQuant software in all 816 
conditions. Data shown for n=1. 817 
 818 
Figure 4: Upd2-dependent nuclear translocation of STAT92E requires Tyr704 819 
phosphorylation but is independent of endocytosis 820 
(A) Representative images of cells treated with control dsRNA or dsRNA targeting 821 
Dome, AP2 or Hrs for 5 days and transfected with STAT92EWT-GFP (day 3) and 822 
treated with 3 nM Upd2-GFP for 0 or 30 mins.  823 
(B) Time-course of nuclear accumulation of STAT92E-GFP following treatment with 824 
Upd2-GFP. Nuclear signal was divided by cytoplasmic signal, and expressed as a 825 
percentage of nuclear STAT92E-GFP after 30mins. Data are presented as mean +/- 826 
s.d. for at least two independent experiments where >15 cells were examined per 827 
experiment. 828 
(C) Quantitation of nuclear versus cytoplasmic STAT92Ewt-GFP and STAT92EY704F-829 
GFP following treatment of cells with Upd2-GFP for the times indicated. Nuclear 830 
signal was divided by cytoplasmic signal, and normalised to 0mins in control cells. 831 
Data are presented as mean +/- s.e.m. where at least 80 cells were imaged from 3 832 
independent experiments.  833 
(D) Quantitation of nuclear STAT92E-GFP versus cytoplasmic STAT92E-GFP 834 
following treatment of cells with control dsRNA or dsRNA targeting Dome, AP2 or 835 
Hrs. Nuclear signal was divided by cytoplasmic signal, and normalised to 0 mins 836 
control cells.  Data are presented as mean +/- s.e.m. for 3 independent experiments 837 
where at least 20 cells were imaged per condition per experiment, with parametric, 838 
unpaired student’s t-test being performed. ****: p≤0.0001; ns is non significant. 839 
 840 
Figure 5: Phosphorylation of Thr702 on STAT92E is essential for its function  841 
(A) Schematic of STAT92E indicating domains, Tyr704 and novel phosphorylation 842 
sites that were identified by mass spectrometry. 843 
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(B) Control (WT) or cells lines lacking STAT92E (crSTAT) cell lines were transfected 844 
with pAc- Ren (RL), 10xSTATluciferase (FL) reporter and pAc5.1(-) for 24 hrs. Cells 845 
were stimulated with 3 nM Upd2-GFP for 30 mins, and then incubated in fresh media 846 
for 18 hrs. Luciferase activity (FL/RL) is expressed as a fold change compared to mock 847 
treated cells transfected with pAc5.1 (-). Graph represents mean +/- s.e.m. of triplicates 848 
from 3 independent experiments. Parametric, unpaired student’s t-test was 849 
performed with ****: p≤0.0001. 850 
(C) STAT92E mutants which cannot be phosphorylated, STAT92ET702V and 851 
STAT92EY704F, inhibit Upd2-GFP-dependent signalling. crSTAT cells were 852 
transfected with pAc-Ren, 10xSTAT-Luciferase and pAc5.1 (-), and/or STAT92E-853 
GFP mutants as indicated. Cells were mock-treated or stimulated with 0.75 nM 854 
Upd2-GFP for 30 mins, and then incubated in fresh media for 18 hrs. Data are mean 855 
+/- s.e.m. from 3 independent experiments, each performed in triplicate and 856 
normalised to cells transfected with pAc5.1 (-). Parametric, unpaired student’s t-test 857 
was performed with **: p≤0.01, ****: p≤0.0001. 858 
(D) Phosphomimetic forms of STAT92E rescue inhibitory effects of T702V on Upd2-859 
GFP-dependent signalling. crSTAT cells were transfected with pAc-Ren, 10xSTAT-860 
Luciferase and pAc5.1 (-) and/or STAT92E-GFP mutants as indicated. Cells were 861 
mock-treated or stimulated with 0.75 nM Upd2-GFP for 30 mins, then incubated in 862 
fresh media for 18 hrs. Luciferase activity (FL/RL) is expressed as a fold change 863 
compared to mock treated cells transfected with pAc5.1 (-). Data is expressed as mean 864 
+/- s.e.m. from 3 independent experiments and normalised to mock-treated cells 865 
transfected with pAc5.1. Parametric, unpaired student’s t-test was performed, with *: 866 
p≤0.05, **: p≤0.01, ***: p≤0.001, ns: non significant. 867 
 868 
Figure 6: Phosphorylation of Thr702 is essential for Tyr704 phosphorylation 869 
(A) T702V mutation prevents STAT92E-GFP nuclear translocation in response to 870 
ligand. Representative images of crSTAT cells transfected with either STAT92EWT-871 
GFP or STAT92ET702V-GFP, and treated with 3 nM Upd2-GFP for 0, 15 or 30 mins.  872 
(B) Nuclear signal was divided by cytoplasmic signal, and normalised to 0 mins 873 
control cells. Data is presented as mean +/-s.e.m. for 3 independent experiments, 874 
where at least 30 cells were imaged per condition per experiment. Parametric, 875 
unpaired student’s t-test being performed. ****: p≤0.0001, ns: non significant 876 
(C) Mutation of Thr702 reduces phosphorylation on Tyr704. S2R+ cells were 877 
transfected with STAT92EWT-GFP or STAT92ET702V-GFP for 2 days prior to treatment 878 
with 3nM Upd2-GFP for 75mins. Cells were lysed and incubated with GFP-trap 879 
beads prior to preparation for mass spectrometry analysis. Histograms present the 880 
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ratios Mod/Base of Y704 phosphorylation site from STAT92EWT-GFP and 881 
STAT92ET702V-GFP calculated by MaxQuant software. Data shown for n=1. 882 
(D) Compartmentalised signalling regulates expression of JAK/STAT targets. 883 
Cartoon depicting how movement of the Upd2/Dome complex along the endocytic 884 
pathway regulates differential gene expression. At the cell surface activated Dome 885 
can result in transcription of a subset of target genes (e.g. lama, shown in green). 886 
Following uncoating of clathrin and AP2 from clathrin coated vesicles, other genes 887 
can be activated (e.g. Luciferase, shown in orange). Hrs selects ubiquitinated cargo 888 
for incorporation into intraluminal vesicles but activated Dome can still signal to 889 
activate other genes (e.g. socs36E, shown in purple) before TSG101 results in its 890 
incorporation into inward invaginations of the endosomal membrane to form intra 891 
luminal vesicles which results in termination of signalling.  892 
(E) Thr702 conservation and location within STAT1 crystal structure. (i) Alignment of 893 
sequences surrounding the conserved Tyr in STAT92E-C (C isoform), STAT92E-F 894 
(long isoform), human STAT1, STAT5a and STAT5b. The conserved Tyr is 895 
highlighted in orange, and a conserved Lys highlighted in green. The Thr residue is 896 
in a yellow box. ii) Crystal structure of STAT1 (PDB:1bf5). iii) Location of the Thr and 897 
Tyr residues within the STAT1 crystal structure. 898 
 899 
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Supplementary Legends 901 
Figure S1: 902 
(A) CME is the route of GFP-Upd2 uptake at low ligand concentrations.  903 
S2R+ cells were treated for 5 days with control, clathrin (CHC) or Dome dsRNA. 904 
Cells were incubated with 3 nM Upd2-GFP for indicated time points at 25°C. 905 
Following acid washes, cell lysates were analysed with an anti-GFP ELISA. 906 
Internalised Upd2-GFP is expressed as percentage of the total amount internalised 907 
at 30 minutes. Graph is a representative experiment where each point is mean of 908 
triplicates +/- s.d. 909 
(B) mRNA levels of dsRNA targets following knockdown. S2R+ cells were treated 910 
with dsRNA 5 days prior to TRIzol RNA extraction. mRNA levels were analysed 911 
using qPCR, with levels of target mRNA normalised to rpl32 mRNA. Ratios are 912 
plotted as fold change compared to control dsRNA for each target mRNA. Graph 913 
represents the mean of triplicates +/- s.d. for at least 2 independent experiments 914 
(Dome = 2 repeats), or mean +/- s.e.m. for at least three independent experiments 915 
(AP2, Hrs and TSG101). Parametric, unpaired student’s t-test was performed to 916 
compare control knockdown with targeted dsRNA knockdown, with ***p≤0.001, 917 
****p≤0.0001. 918 
(C) Lysates from S2R+ cells transfected with FLAG-tagged Dome wild-type and 919 
mutants were prepared and subjected to SDS-PAGE and Western blotting with 920 
antibodies to FLAG and β-actin. The ratio of transfected Dome-FLAG construct is 921 
expressed as a function of the amount of β-actin. Graph is the mean ± s.d. of at least 2 922 
independent experiments. Using student’s t-test, there was no statistical difference 923 
between wild-type and mutant constructs.  924 
(D) Percentage of biotinylated Dome-FLAG at cell surface compared to total levels of 925 
transfected Dome-FLAG in cells expressing wild-type or mutant Dome-FLAG 926 
constructs. Using student’s t-test, there was no statistical difference between wild-type 927 
and mutant constructs. 928 
(E) Dome is internalised efficiently in the absence of ligand. Sample immunoblot of 929 
cells transfected with DomeWT-FLAG for 48hrs prior to cell surface biotinylation and 930 
endocytosis for 15 minutes +/- Upd2-GFP, followed by treatment +/- MESNa. 931 
Western blots were probed with antibodies as indicated.  932 
(F) Sample immunoblot of lysates from cells transfected with DomeWT-FLAG or 933 
DomeE980A-FLAG for 48 hrs prior to cell surface biotinylation and incubation at 25°C 934 
for times indicated +/- Upd2-GFP followed by treatment +/- MESNa. Western blots 935 
were probed with antibodies as indicated.   936 
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(G) Quantitation of internalisation of DomeWT-FLAG and DomeE980A-FLAG.  937 
Percentage of cell-surface receptor that is internalised after 15 mins at 25°C. 938 
Background of biotinylated cell surface Dome-FLAG after 0 mins endocytosis and 939 
MESNa treatment was subtracted and internalised Dome-FLAG was then calculated 940 
as a percentage of total cell surface Dome-FLAG prior to MESNa treatment. Graphs 941 
represent mean +/- s.d. for 2 independent experiments and no significant differences 942 
were observed. 943 
 944 
Figure S2:  945 
(A) Sample immunoblot of relative transfection efficiencies of DomeWT-FLAG, 946 
DomeallA-FLAG, DomeY966A/Q969A-FLAG and Dome P925I-FLAG. Blots were probed with 947 
antibodies as indicated. 948 
(B) lama expression is independent of endocytosis. S2R+ cells were treated with 949 
dsRNA against AP2, Hrs and TSG101 as well as non-targeting (control) dsRNA for 5 950 
days. Cells were incubated with 3 nM Upd2-GFP for 2.5 hrs prior to RNA extraction. 951 
lama mRNA levels were normalised to that of reference gene Rpl32, and presented 952 
as fold change compared to mock-treated control samples. Results are expressed as 953 
means of triplicates +/- s.e.m. for 3 independent experiments.  954 
 955 
Figure S3: STAT92E phosphorylation is not regulated by endocytosis. 956 
Representative immunoblot of control vs AP2, Hrs and TSG101 knockdown S2R+ 957 
cells treated with 3 nM Upd2-GFP at 25°C for the indicated times. Cells were treated 958 
with targeting dsRNA and incubated for 5 days at 25°C. Total protein extract was 959 
analysed by SDS-PAGE and immunoblotted with anti-STAT92E antibodies. 960 
 961 
Figure S4: Generation and characterization of STAT92E negative S2R+ cells. 962 
(A) Immunoblot and quantification demonstrating levels of STAT92E protein in cells 963 
transfected with pAc-sgRNA-Cas9 targeting STAT92E for 3 days, and then either 964 
with or without puromycin selection as indicated. Blots were probed with antibodies 965 
as indicated.  966 
(B) T7-endonuclease assay demonstrates Cas9 induced mutation in the STAT92E 967 
gene. Genomic DNA was extracted from WT and crSTAT2 cell lines, and a 989bp 968 
region around the sgRNA target site was amplified by PCR. Addition of T7 969 
endonuclease to the PCR product causes multiple bands for crSTAT2 cell line but 970 
not WT cells.  971 
(C) Mutation of Lys187 increases STAT92E signalling. crSTAT cells were transfected 972 
with pAc-Ren, 10xSTAT-Luciferase and pAc5.1 (-), STAT92EWT-GFP or 973 
 33 
STAT92EK187R-GFP. Cells were stimulated with 0.75 nM Upd2-GFP for 30 mins, then 974 
incubated in fresh media for 18 hrs followed by measurement of bioluminescence. 975 
Data is mean +/- s.e.m. from 3 independent experiments and normalised to cells 976 
transfected with pAc5.1 (-) and treated with 0 nM Upd2-GFP. *: p<0.05; **: p<0.01. 977 
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N-term Coiled-coil DNA binding Linker/SH2 TA domain 





























































































































































































































































































Upd2-GFP: - - +
φKXE - consensus
704VLDPVTGYVKSTLHV718STAT92E-F
694DGPKGTGYIKTELIS708hSTAT1
692TAKAADGYVKPQIKQ706hSTAT5b
687LAKAVDGYVKPQIKQ701hSTAT5a
697RQDPVTGYVKSTLHV711STAT92E-C
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